Grant: Master's Award: Canada Graduate Scholarships
McGill University
$27,000.00
Hematopoietic stem and progenitor cells as mediators of trained immunity in rheumatoid arthritis
FY 2024-25
Summary
Systemic autoimmune rheumatic diseases (SARDs) are a group of chronic inflammatory disorders that result in pain, disability, and premature mortality, with rheumatoid arthritis (RA) being the most common. Tissue damage in RA and other SARDs is caused by the patients immune system. Trained immunity is a newly discovered form of immunological memory that affects specifically the innate immune system. As most innate immune cells are short-lived, their long-lived precursors, hematopoietic stem and progenitor cells (HSPCs), are considered as the primary carriers of trained immunity. However, the role of trained immunity in RA and other SARDs is poorly understood. RECENT PROGRESS: Our team demonstrated that HSPCs of arthritis afflicted mice give rise to functionally distinct innate immune cells, even when grown outside of the inflammatory milieu. Furthermore, in human arthritis, HSPCs were shown to undergo major changes in gene expression and function, supporting the induction of trained immunity. OBJECTIVES: This project will thus characterize the role of trained immunity in RA and its effects on innate immune cell functions in RA patients. METHODOLOGY: HSPCs isolated from RA patients and healthy controls will be differentiated in culture into two types of innate immune cells: monocytes and neutrophils. The cells will be analyzed for their responses to immune stimulation, inflammatory protein production, induction of activation markers, gene expression, and epigenetic profiles, comparing patients to healthy controls, as well as males and females across both groups. SIGNIFICANCE: This project will provide insight into the role of HSPCs in maintaining trained immunity in the context of RA and demonstrate novel avenues for therapeutic interventions.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
530067
Name
Pozzebon Bianca
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Hematopoietic stem and progenitor cells as mediators of trained immunity in rheumatoid arthritis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autoimmune Diseases; Bioinformatics; Chronic Inflammation; Genomics; Hematopoietic Stem And Progenitor Cells; Innate Immunity; Monocytes; Neutrophils; Rheumatoid Arthritis; Trained Immunity
Abstract
Systemic autoimmune rheumatic diseases (SARDs) are a group of chronic inflammatory disorders that result in pain, disability, and premature mortality, with rheumatoid arthritis (RA) being the most common. Tissue damage in RA and other SARDs is caused by the patients immune system. Trained immunity is a newly discovered form of immunological memory that affects specifically the innate immune system. As most innate immune cells are short-lived, their long-lived precursors, hematopoietic stem and progenitor cells (HSPCs), are considered as the primary carriers of trained immunity. However, the role of trained immunity in RA and other SARDs is poorly understood. RECENT PROGRESS: Our team demonstrated that HSPCs of arthritis afflicted mice give rise to functionally distinct innate immune cells, even when grown outside of the inflammatory milieu. Furthermore, in human arthritis, HSPCs were shown to undergo major changes in gene expression and function, supporting the induction of trained immunity. OBJECTIVES: This project will thus characterize the role of trained immunity in RA and its effects on innate immune cell functions in RA patients. METHODOLOGY: HSPCs isolated from RA patients and healthy controls will be differentiated in culture into two types of innate immune cells: monocytes and neutrophils. The cells will be analyzed for their responses to immune stimulation, inflammatory protein production, induction of activation markers, gene expression, and epigenetic profiles, comparing patients to healthy controls, as well as males and females across both groups. SIGNIFICANCE: This project will provide insight into the role of HSPCs in maintaining trained immunity in the context of RA and demonstrate novel avenues for therapeutic interventions.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pozzebon, Bianca
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~